Skip to main content

Share story

AI

Brockman says enterprise sales now provide most of OpenAI's revenue

Brockman says enterprise sales now provide most of OpenAI's revenue Image: Primary
OpenAI President Greg Brockman said enterprise sales now generate the majority of the company's revenue, Reuters reported. Speaking in Napa, California, on November 4, he also expressed confidence that OpenAI could be ready for an initial public offering in 2027. The revenue mix moves beyond OpenAI's March 31 benchmark, when the company said enterprise contributed more than 40% of revenue and was on track to reach parity with consumer revenue by year-end. Brockman's response about IPO readiness did not commit the company to a 2027 listing.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Unite.AI and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Infrastructure
Infrastructure

Google plans $15B Malaysian data center and cloud investment

Google plans to spend $15B in Malaysia during 2027 and 2028 on data centers, cloud operations, water supplies, power generation and training, The Next Web reports. Alphabet chief investment officer Ruth Porat announced the plan at an event in Kuala Lumpur.

Capital AI
Capital AI

Pliant raises $80M for expansion and AI payment workflows

Pliant raised an $80M Series C led by Seaya Nova and Speedinvest, the Berlin fintech said Wednesday. The funding will support expansion in the US and Canada, entry into additional markets and its AI roadmap.

Robotics Capital
Robotics Capital

Aformic raises $6.95M to expand industrial robotics

Aformic raised a $6.95M seed round led by Veteran Ventures Capital, the industrial robotics company said Wednesday. It will use the funding for engineers, sales staff, its Qursor software and new robots, including machines intended to help build and maintain AI data centres.

AI Capital
AI Capital

Isomorphic Labs seeks roughly $5 billion in funding talks

Alphabet's Isomorphic Labs is in talks to raise roughly $5 billion to support its use of artificial intelligence for drug discovery, Bloomberg reported, citing people familiar with the matter. The financing remains under discussion rather than a completed fundraising.